CAS No. |
623165-93-5 |
中文名称 |
(3R,6'S,9'R)-5-(2,2,2-三氟乙基)-2'-[(E)-3-[4-(三氟甲基)哌啶-1-基]丙-1-烯-1-基]-5',6',7',8',9',10'-六氢螺[[1,2,5]噻二唑烷-3,11'-[6,9]亚甲基并苯并环辛烯]-1,1-二氧化物 |
英文名称 |
(3R,6'S,9'R)-5-(2,2,2-Trifluoroethyl)-2'-((E)-3-(4-(trifluoromethyl)piperidin-1-yl)prop-1-en-1-yl)-5',6',7',8',9',10'-hexahydrospiro[[1,2,5]thiadiazolidine-3,11'-[6,9]methanobenzo[8]annulene] 1,1-dioxide |
别名 |
(3'R,6S,9R)-5,6,7,8,9,10-Hexahydro-5'-(2,2,2-trifluoroethyl)-2-[(1E)-3-[4-(trifluoromethyl)-1-piperidinyl]-1-propen-1-yl]spiro[6,9-methanobenzocyclooctene-11,3'-[1,2,5]thiadiazolidine] 1',1'-dioxide;MRK 003;(3'R,6S,9R)-5,6,7,8,9,10-Hexahydro-5'-(2,2,2-trifluoroethyl)-2-[(1E)-3-[4-(trifluoromethyl)-1-;CS-771;Spiro[6,9-methanobenzocyclooctene-11,3'-[1,2,5]thiadiazolidine], 5,6,7,8,9,10-hexahydro-5'-(2,2,2-trifluoroethyl)-2-[(1E)-3-[4-(trifluoromethyl)-1-piperidinyl]-1-propen-1-yl]-, 1',1'-dioxide, (3'R,6S,9R)-;2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.0 3,8]trideca-3(8),4,6-triene] 1,1-dioxide |
标准英文名 |
(3R,6'S,9'R)-5-(2,2,2-trifluoroethyl)-2'-((E)-3-(4-(trifluoromethyl)piperidin-1-yl)prop-1-en-1-yl)-5',6',7',8',9',10'-hexahydrospiro[[1,2,5]thiadiazolidine-3,11'-[6,9]methanobenzo[8]annulene] 1,1-dioxide |
MDL No. |
MFCD23136012 |
分子式 |
C25H31F6N3O2S |
分子量 |
551.60
|
精确分子量 |
551.20
|
SMILES |
FC(C1CCN(C/C=C/C2=CC=C3C(C[C@@]4([H])CC[C@@]([C@@]4(CN5CC(F)(F)F)NS5(=O)=O)([H])C3)=C2)CC1)(F)F |
标准SMILES |
O=S1(=O)N[C@@]2(CN1CC(F)(F)F)[C@H]1CC3=CC(/C=C/CN4CCC(CC4)C(F)(F)F)=CC=C3C[C@@H]2CC1 |
用途 |
It is a potent, selective, and orally active γ-secretase inhibitor; reduces brain Aβ production in vivo; induces caspase-dependent apoptosis; and inhibits tumor cell proliferation both in vitro and in vivo. |
InChIKey |
NKHUILHBYOOZDF-NCOIWELASA-N |